HOLN:SIX
Holcim Ltd
Data as of 2026-03-10 - not real-time
CHF 63.88
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Holcim AG is trading at CHF 63.88, well above its DCF‑derived fair value of CHF 39.46, indicating the stock is currently overvalued. The Relative Strength Index sits at 27, flagging an oversold condition, while the MACD shows a bearish divergence, suggesting limited short‑term upside. Price action is hovering just above the computed support level of CHF 60.10 and remains far below the resistance at CHF 78.58, leaving room for a modest rebound but also exposing the share to downside risk. Volatility is elevated at 44% over the past 30 days, yet the beta of 0.52 points to lower systematic risk compared with the market. Fundamentally, revenue has contracted by 3.6% year‑over‑year and gross margins sit at 42.3%, reflecting pressure on the building‑materials sector. The company’s forward earnings per share of 4.12 versus a trailing EPS of 0.70 translates to a forward P/E of 15.5, a significant improvement over the trailing P/E of 91.2. Analysts project a median target price of CHF 78.5, implying a potential upside of roughly 23% from current levels. However, the dividend yield of 4.85% is accompanied by an unsustainable payout ratio exceeding 400%, raising concerns about dividend continuity. The balance sheet shows a debt‑to‑equity of 57.5, and net debt remains high relative to cash, limiting financial flexibility. Overall, the mix of technical oversold signals, strong dividend yield, but questionable sustainability and an overvalued price creates a nuanced investment picture.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI indicating oversold conditions
- Bearish MACD divergence
- Proximity to technical support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings improvement and lower forward P/E
- Analyst median target price suggesting upside
- Attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap between market price and DCF fair value
- High payout ratio questioning dividend durability
- Cyclical exposure of the basic materials sector
Key Metrics & Analysis
Financial Health
Revenue Growth-3.60%
Profit Margin83.81%
P/E Ratio91.3
ROE2.09%
ROA3.16%
Debt/Equity57.49
P/B Ratio2.3
Op. Cash FlowCHF2.8B
Free Cash FlowCHF1.9B
Technical Analysis
TrendNeutral
RSI27.2
SupportCHF 60.10
ResistanceCHF 78.58
MA 20CHF 71.09
MA 50CHF 75.53
MA 200CHF 71.36
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair ValueCHF 39.46
Target PriceCHF 78.71
Upside/Downside23.22%
GradeOvervalued
TypeValue
Dividend Yield4.85%
Risk Assessment
Beta0.52
Volatility44.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.